| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $6.28M | $6.63M | $5.72M | $7.74M | $6.15M |
| SG&A | $8.46M | $5.00M | $4.13M | $5.54M | $5.20M |
| Operating Income | -$14.74M | -$11.63M | -$9.86M | -$13.28M | -$11.36M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$13.14M | -$11.44M | -$10.74M | -$13.17M | -$11.31M |
| EPS (basic) | -0.2900 | -0.7300 | -1.0500 | -1.8100 | -1.5900 |
| EPS (diluted) | -0.2900 | -0.7300 | -1.0500 | -1.8100 | – |
| Shares (diluted) | $45.79M | $15.64M | $10.20M | $7.26M | – |